You searched for: cancer
1 to 2 of 2 results
Show
results per page
Matched phrases in profile:
Using the MCoTI-II cyclotide scaffold to design a stable cyclic peptide antagonist of SET, a protein overexpressed in human cancer… Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy… against the cancer cell lines MM96L, HeLa and BGC-823. The novel cyclotides reported here: (1…
Matched phrases in profile:
eMethylsorb: rapid quantification of DNA methylation in cancer cells on screen-printed gold electrodes… Combined TMPRSS2:ERG, PCA3 and SChLAP1 RNA in Urine for selective detection of Aggressive Prostate Cancer… biomarkers in prostate cancer liquid biopsies (with a particular interest in fusion genes), and the… Microfabricated devices for the electrochemical detection of single DNA base changes in cancer cell…
Dr Kevin M. Koo is currently a National Health and Medical Research Council (NHMRC) Investigator Fellow at The University of Queensland Centre for Clinical Research (UQCCR). Dr Koo was awarded his PhD (Dean’s Award for Outstanding Thesis) from the Australian Institute for Bioengineering & Nanotech …
To date, Dr Koo's research has contributed Knowledge Impact by:
1 to 2 of 2 results